Estuary secures $103m to advance kidney disease gene therapies

Positive

AI Analysis

Estuary Biotherapeutics has launched with $103m in total committed financing to develop targeted gene therapies for kidney diseases.

Launched with $103m in total committed financing to develop targeted gene therapies for kidney diseases

Importance:7/10

Sentiment:

0.60

gene therapykidney diseasefinancingcompany launchstartup

Read the original article

Published by Pharmaceutical Technology on October 19, 2026 7:32 AM